Cite
Radioimmunotherapy of MCF7 breast cancer cell line with ^{131}I-PR81 monoclonal antibody against MUC1: Comparison of direct and indirect radioiodination methods.
MLA
Mohammadnejad, Javad, et al. “Radioimmunotherapy of MCF7 Breast Cancer Cell Line with ^{131}I-PR81 Monoclonal Antibody against MUC1: Comparison of Direct and Indirect Radioiodination Methods.” Human Antibodies, vol. 19, no. 1, Mar. 2010, pp. 15–25. EBSCOhost, https://doi.org/10.3233/HAB-2010-0216.
APA
Mohammadnejad, J., Rasaee, M. J., Babaei, M. H., Paknejad, M., Hasan, Z. M., Salouti, M., Gandomkar, M., & Sadri, K. (2010). Radioimmunotherapy of MCF7 breast cancer cell line with ^{131}I-PR81 monoclonal antibody against MUC1: Comparison of direct and indirect radioiodination methods. Human Antibodies, 19(1), 15–25. https://doi.org/10.3233/HAB-2010-0216
Chicago
Mohammadnejad, Javad, Mohammad Javad Rasaee, Mohammad Hosein Babaei, Malihe Paknejad, Zahir Mohammad Hasan, Mojtaba Salouti, Mostafa Gandomkar, and Keyvan Sadri. 2010. “Radioimmunotherapy of MCF7 Breast Cancer Cell Line with ^{131}I-PR81 Monoclonal Antibody against MUC1: Comparison of Direct and Indirect Radioiodination Methods.” Human Antibodies 19 (1): 15–25. doi:10.3233/HAB-2010-0216.